White House unveils 'TrumpRx' drug platform, amid blockbuster deal with Pfizer
President Donald Trump is shaking up the pharmaceutical game with a bold new move! The White House is rolling out TrumpRx, a government-run website where everyday folks can buy select drugs at slashed prices negotiated directly by Uncle Sam, as the Wall Street Journal reports.
This isn’t just a press release; it’s a direct jab at Big Pharma’s bloated pricing schemes.
Alongside this, Pfizer is stepping up with price cuts on several U.S. medications and a massive $70 billion investment in American manufacturing, all tied to Trump’s push for cheaper drugs and domestic production.
For months, President Trump has been turning the screws on drug companies, demanding they slash costs for American patients. In a July letter, he urged pharmaceutical giants to join a direct-to-consumer platform with pricing on par with other developed nations.
That’s not a suggestion; it’s a battle cry against the progressive agenda that’s let drug costs spiral out of control.
Pfizer’s products will be offered on a website that hasn’t yet launched, called TrumpRx.gov. The program, at least initially, seems to be geared toward patients who access care through Medicaid. But officials said during a press conference they see a future where these prices will also apply in the Medicare program and commercial plans.
Look for the web site TrumpRx.gov to launch early 2026.
Read more...
